Women's Hormone & Menopause Panel

Elyon Clinic offers a women's hormone and menopause panel for women navigating perimenopause and menopause, experiencing unexplained hormonal symptoms, or seeking a baseline assessment of their reproductive and metabolic hormone status. The clinic takes a practical, patient-centred approach to women's hormonal health, offering clear communication and transparent pricing in contrast to the opaque billing that can characterise specialist-only pathways.

The core panel measures oestradiol (E2), follicle-stimulating hormone (FSH) and luteinising hormone (LH) — the key markers for assessing ovarian reserve and menopausal status. Elevated FSH in the context of low oestradiol is a reliable indicator of ovarian insufficiency or menopause. Progesterone is included to assess luteal function in women who are still cycling but experiencing cycle irregularity or premenstrual symptoms. Prolactin is measured because…

Thyroid function (TSH, free T4) is a standard inclusion because hypothyroidism is common in women, shares many symptoms with menopause — including fatigue, weight changes, mood disturbance and brain fog — and can compound menopausal symptoms if untreated. DHEA-S and testosterone are measured where there is concern about adrenal function or symptoms of androgen excess or deficiency.